argenx
argenx is an antibody therapies founded in 2008 by Tim Van Hauwermeiren, Hans J. W. de Haard and Torsten Dreier.
$2.0b
Money raised
Overview
argenx is an antibody therapies founded in 2008 by Tim Van Hauwermeiren, Hans J. W. de Haard and Torsten Dreier.
-
Websites:
- Business model: B2B
- Headquarters: Rotterdam
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti* Va* Ha | - | - | |
| Ha** J. W. de Ha*** | - | - | |
| To Dr**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti* Va* Ha | - | - | |
| Di** Be** | - | - | - |
| We**** La** |
|
- | |
| Ka** Gu**** | - | - | - |
| Ke*** Wo*** | - | - | |
| Wi* Pa*** | - | - | |
| Ar*** Le**** | - | - | |
| An**** Wi** | - | - | |
| Ma** Sc** | - | - | |
| Pe*** Ve** | - | - | - |
| Do* de** | - | - | |
| Pa**** M. Kl*** | - | - | |
| A.** Ro** | - | - | - |
| Ja*** M. Da** | - | - |
Industries
argenx is active in the following industries: